Trial record 3 of 4 for:    regn2477

Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03710941
Recruitment Status : Not yet recruiting
First Posted : October 18, 2018
Last Update Posted : November 12, 2018
Information provided by (Responsible Party):
Regeneron Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : June 26, 2020
  Estimated Study Completion Date : September 4, 2020